Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 83: Line 83:
! style="background: #FFFF00; width: 150px;" | Recomendacations !! style="background: #FFFF00; width: 150px;" | Class !! style="background: #FFFF00; width: 150px;" | Level !! style="background: #FFFF00; width: 150px;" | References
! style="background: #FFFF00; width: 150px;" | Recomendacations !! style="background: #FFFF00; width: 150px;" | Class !! style="background: #FFFF00; width: 150px;" | Level !! style="background: #FFFF00; width: 150px;" | References
|-
|-
! colspan="4" |History and clinical assessment
! colspan="4"  align="left" |History and clinical assessment
|-
|-
! style="padding: 5px 5px; background: #FFFFE0; " |In all patients with suspected
! style="padding: 5px 5px; background: #FFFFE0; "  align="left" |In all patients with suspected


AAS, pre-test probability
AAS, pre-test probability
Line 100: Line 100:
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |
|-
|-
! colspan="4" | Laboratory testing
! colspan="4"  align="left" | Laboratory testing
|-
|-
! style="padding: 5px 5px; background: #FFFFE0; " align="left" |In case of suspicion of AAS,
! style="padding: 5px 5px; background: #FFFFE0; " align="left" |In case of suspicion of AAS,
Line 115: Line 115:
|
|
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; " |In case of low clinical
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In case of low clinical


probability of AAS, negative D-dimer
probability of AAS, negative D-dimer
Line 128: Line 128:
|
|
|-
|-
! style="padding: 5px 5px; background: #FFFFE0; " |In case of intermediate clinical
! style="padding: 5px 5px; background: #FFFFE0; "  align="left" |In case of intermediate clinical


probability of AAS with a
probability of AAS with a
Line 141: Line 141:
|
|
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; " |In patients with high probability
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In patients with high probability


(risk score 2 or 3) of AD,
(risk score 2 or 3) of AD,
Line 152: Line 152:
|
|
|-
|-
! colspan="4" |Imaging
! colspan="4" align="left" |Imaging
|-
|-
!TTE is recommended as an
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |TTE is recommended as an


initial imaging investigation.
initial imaging investigation.
Line 161: Line 161:
!
!
|-
|-
!In unstabled patients with a
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In unstabled patients with a


suspicion of AAS, the following
suspicion of AAS, the following
Line 184: Line 184:
!
!
|-
|-
!In stable patients with a
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In stable patients with a


suspicion of AAS, the
suspicion of AAS, the
Line 214: Line 214:
!
!
|-
|-
!In case of initially negative
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In case of initially negative


imaging with the persistence of
imaging with the persistence of
Line 227: Line 227:
!
!
|-
|-
!Chest X-ray maybe
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |Chest X-ray maybe


considered in cases of low
considered in cases of low
Line 236: Line 236:
!
!
|-
|-
!In case of uncomplicated
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In case of uncomplicated


Type B AD treated medically,
Type B AD treated medically,

Revision as of 03:31, 25 December 2019

Recomendacations Class Level References
History and clinical assessment
In all patients with suspected

AAS, pre-test probability

assessment is recommended,

according to the patient’s

condition, symptoms, and

clinical features.

I B
Laboratory testing
In case of suspicion of AAS,

the interpretation of

biomarkers should always be

considered along with the pretest

clinical probability.

IIa B
In case of low clinical

probability of AAS, negative D-dimer

levels should be

considered as ruling out the

diagnosis.

IIa C
In case of intermediate clinical

probability of AAS with a

positive (point-of-care) D-dimer

test, further imaging

tests should be considered.

IIa B
In patients with high probability

(risk score 2 or 3) of AD,

testing of D-dimers is not

recommended.

III C
Imaging
TTE is recommended as an

initial imaging investigation.

I C
In unstabled patients with a

suspicion of AAS, the following

imaging modalities are

recommended according to

local availability and expertise:

TOE I C
CT I C
In stable patients with a

suspicion of AAS, the

following imaging modalities

are recommended (or should

be considered) according to

local availability and expertise:

CT I C
MRI I C
TOE IIa C
In case of initially negative

imaging with the persistence of

suspicion of AAS, repetitive

imaging (CT or MRI) is

recommended.

I C
Chest X-ray maybe

considered in cases of low

clinical probability of AAS.

IIb C
In case of uncomplicated

Type B AD treated medically,

repeated imaging (CT or

MRI)e during the first days is

recommended.

I C